Home Regulation
Regulation
Pharma services is creating cross-border opportunities, but GPs should be aware of regulatory and structural issues at play in different jurisdictions, say McDermott Will & Emery’s Kristian Werling and Ellie West.
A raft of regulatory changes coming down the line means fund managers are needing to rely on third-party providers more than ever.
Delegates at the HKVCA’s China Private Equity Summit on Tuesday heard that being an APAC or China-based investor was no longer necessarily a boon when accessing overseas investment opportunities.
The trade group has issued guidance to address concerns over conflicts and the speed of GP-led deals.
Compliance's 'one-way ratchet' may mean fewer, bigger firms in the private funds industry.
GPs will soon have to report on sponsor-initiated secondaries deals within 60 days from the end of each quarter, after the US regulator voted through the proposals Wednesday.
LinkedIn has become a crucial component of the fundraising process as LPs scrutinise social media in a bid to support decision-making.
With the industry under increased scrutiny, sponsors must be more active on legislative and regulatory engagement, say Baker McKenzie’s Michael Fieweger and John Fedele.
PE firms are doubling down on ESG to boost portfolio companies’ resiliency and their appeal to buyers, customers and talent, say Tania Carnegie and Glenn Mincey at KPMG.
Jurisdictions are adapting to meet emerging managers’ evolving requirements, allowing new funds to focus on their core business areas, says Elliot Refson at Jersey Finance.